Table 2. Treatment details for both patient groups.
| Chemotherapy group (n=85) | Nonchemotherapy group (n=43) | |
|---|---|---|
| Tumour grade | ||
| Grade 1 | 4 | 16 |
| Grade 3 | 31 | 25 |
| Grade 3 | 50 | 2 |
| Type of surgery | ||
| WLE | 47 | 36 |
| Mastectomy | 26 | 7 |
| Mastectomy and reconstruction | 7 | 1 |
| Bilateral mastectomy | 4 | |
| Missing | 1 | |
| Type of chemotherapy | ||
| FECa × 6 cycles | 51 | |
| FECb × 8 cycles | 8 | |
| CMF × 6 cycles | 2 | |
| 4FEC 4 docetaxel × 8 cycles | 3 | |
| AC × 4 cycles | 4 | |
| EC × 6 cycles | 9 | |
| 4EC 4 paclitaxel × 8 cycles | 5 | |
| 4E 4CMF × 8 cycles | 1 | |
| 4E 4FEC × 8 cycles | 1 | |
Data missing from one patient.
Data missing from one patient.